Page last updated: 2024-08-22

lutetium and Rheumatoid Arthritis

lutetium has been researched along with Rheumatoid Arthritis in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Escudero-Castellanos, A; Ferro-Flores, G; Gibbens-Bandala, BV; Isaac-Olive, K; Morales-Avila, E; Ocampo-GarcĂ­a, BE; Trujillo-Nolasco, RM1
Chakraborty, S; Dash, A; Kamaleshwaran, K; Rajeswari, A; Sarma, HD; Shinto, A; Thirumalaisamy, P; Vimalnath, KV1

Trials

1 trial(s) available for lutetium and Rheumatoid Arthritis

ArticleYear
Preparation, evaluation, and first clinical use of 177Lu-labeled hydroxyapatite (HA) particles in the treatment of rheumatoid arthritis: utility of cold kits for convenient dose formulation at hospital radiopharmacy.
    Journal of labelled compounds & radiopharmaceuticals, 2014, Jun-15, Volume: 57, Issue:7

    Topics: Adult; Animals; Arthritis, Rheumatoid; Female; Humans; Hydroxyapatites; Isotope Labeling; Knee Joint; Lutetium; Male; Middle Aged; Radioisotopes; Radiopharmaceuticals; Rats; Rats, Wistar; Tissue Distribution; Tomography, Emission-Computed, Single-Photon

2014

Other Studies

1 other study(ies) available for lutetium and Rheumatoid Arthritis

ArticleYear
Preparation and in vitro evaluation of radiolabeled HA-PLGA nanoparticles as novel MTX delivery system for local treatment of rheumatoid arthritis.
    Materials science & engineering. C, Materials for biological applications, 2019, Volume: 103

    Topics: Animals; Arthritis, Rheumatoid; Drug Evaluation, Preclinical; Hyaluronic Acid; Isotope Labeling; Lutetium; Methotrexate; Mice; Polylactic Acid-Polyglycolic Acid Copolymer; Radiopharmaceuticals; RAW 264.7 Cells

2019